Popular Posts: 4 Pharmaceutical Stocks to Buy Now12 Oil and Gas Stocks to Buy Now6 Biotechnology Stocks to Sell Now Recent Posts: 5 Stocks With Ugly Sales Growth — HTS MITT MNKD UEC IDIX 10 Medical Devices Stocks to Buy Now 5 Stocks With Awful Operating Margin Growth — CTEL TWGP TSRA NYNY SCHN View All Posts This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
Hatteras Financial () is a mortgage real estate investment trust. HTS also gets F’s in Earnings Growth, Earnings Momentum, Analyst Earnings Revisions, Cash Flow and Operating Margin Growth. .
AG Mortgage Investment Trust, Inc. () focuses on investing, acquiring and managing a portfolio of residential mortgage assets, and other real estate-related securities and financial assets. MITT gets F’s in Earnings Growth, Earnings Momentum, Earnings Surprises, Equity, Cash Flow and Operating Margin Growth as well. .
MannKind Corporation () is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. MNKD also gets an F in Cash Flow. .
Uranium Energy () is an exploration-stage company that explores and develops mineral properties in the United States and Paraguay. UEC gets F’s in Analyst Earnings Revisions, Equity and Cash Flow as well. .
Idenix Pharmaceuticals, Inc. () is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. IDIX also gets F’s in Earnings Growth, Equity and Cash Flow. .
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
No comments:
Post a Comment